Evolent Health, Inc.
US ˙ NYSE ˙ US30050B1017

Introduction

This page provides a comprehensive analysis of the known insider trading history of Brendan B Springstubb. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4. Despite these restrictions, academic research suggests that insiders - in general - tend to outperform the market in their own companies.

Average Trade Profitability

The average trade profitability is the average return of all the open market purchases made by the insider in the last three years. To calculate this, we examine every open-market, unplanned purchase made by the insider, excluding all trades that were marked as part of a 10b5-1 trading plan. We then calculate the average performance of those trades over 3, 6, and 12 months, averaging each of those durations to generate a final performance metric for each trade. Finally, we average all of the performance metrics to calculate a performance metric for the insider. This list only includes insiders that have made at least three trades in the last two years.

If this insiders trade profitability is "N/A", then the insider either has not made any open-market purchases in the last three years, or the trades they’ve made are too recent to calculate a reliable performance metric.

Update Frequency: Daily

See the list of most profitable insider traders.

Companies with Reported Insider Positions

The SEC filings indicate Brendan B Springstubb has reported holdings or trades in the following companies:

Security Title Latest Reported Holdings
US:EVH / Evolent Health, Inc. Director 48,821
US:STKL / SunOpta Inc. Director 0
How to Interpret the Charts

The following charts show the stock performance of securities subsequent to each open-market, non-planned trade made by Brendan B Springstubb. Non-planned trade are trades that were not made as part of a 10b5-1 trading plan. The stock performance is charted as cumulative percent change in share price. For example, if an insider trade was made on January 1, 2019, the chart will show the daily percent change of the security to the present day. If the share price were to go from $10 to $15 during this time, the cumulative percent change in share price would be 50%. A change in price from $10 to $20 would be 100%, and a change in price of $10 to $5 would be -50%.

Ultimately, we are trying to determine how closely the insider’s trades correlate to excess returns (positive or negative) in the share price in order to see if the insider is timing their trades to profit from insider information. Consider the situation where an insider was doing this. In this situation, we would expect either (a) positive returns after purchases, or (b) negative returns after sales. In the case of (a), the PURCHASE chart would show a series of upwardly sloping curves, indicating positive returns after each purchase transaction. In the case of (b), the SALE chart would show a series of downward sloping curves, indicating negative returns after each sale transaction.

However, this alone is not enough to draw conclusions. If, for example, the share price of the company was in a non-cyclical climb over many years, then we would expect all the post-purchase plots to be upwardly sloping. Likewise, non-cyclical declines over many years would result in downward sloping post-trade plots. Neither of these charts would suggest insider trading activity.

The strongest indicator would be a situation where the share price was extremely cyclical, and there were both positive signals in the PURCHASE chart and negative plots on the SALE chart. This situation would be highly suggestive of an insider that was timing trades to their financial advantage.

Insider Purchases EVH / Evolent Health, Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EVH / Evolent Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2025-03-07 EVH Springstubb Brendan B 15,000 9.2700 15,000 9.2700 139,050 118 11.7900 37,800 27.18
2025-03-04 EVH Springstubb Brendan B 5,000 8.7500 5,000 8.7500 43,750

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EVH / Evolent Health, Inc. Insider Trades
Insider Sales EVH / Evolent Health, Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EVH / Evolent Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

EVH / Evolent Health, Inc. Insider Trades
Insider Purchases STKL / SunOpta Inc. - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in EVH / Evolent Health, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STKL / SunOpta Inc. Insider Trades
Insider Sales STKL / SunOpta Inc. - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in EVH / Evolent Health, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Ticker Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider and security combination

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

STKL / SunOpta Inc. Insider Trades
Insider Trading History

This table shows the complete list of insider trades made by Brendan B Springstubb as disclosed to the Securities Exchange Commission (SEC).

File Date Tran Date Form Ticker Security Code 10b5-1 Shares Remaining Shares Percent
Change
Share
Price
Tran
Value
Remaining
Value
2025-06-09 2025-06-05 4 EVH Evolent Health, Inc.
Class A Common Stock
A - Award 21,979 48,821 81.88
2025-03-10 2025-03-07 4 EVH Evolent Health, Inc.
Class A Common Stock
P - Purchase 15,000 26,842 126.67 9.27 139,050 248,825
2025-03-05 2025-03-04 4 EVH Evolent Health, Inc.
Class A Common Stock
P - Purchase 5,000 11,842 73.08 8.75 43,750 103,618
2025-03-05 2025-03-03 4 EVH Evolent Health, Inc.
Class A Common Stock
A - Award 6,842 6,842
2025-02-14 3 EVH Evolent Health, Inc.
No securities beneficially owned
0
2020-06-16 2020-06-14 4 STKL SunOpta Inc.
Restricted Stock Units
M - Exercise -24,194 0 -100.00
2020-06-16 2020-06-14 4 STKL SunOpta Inc.
Common Shares
M - Exercise 24,194 97,391 33.05
2020-02-04 2020-01-31 4 STKL SunOpta Inc.
Common Shares
A - Award 7,882 73,197 12.07 2.49 19,626 182,261
2020-02-04 2019-10-25 4 STKL SunOpta Inc.
Common Shares
A - Award 9,645 65,315 17.33 1.84 17,747 120,180
2019-07-22 2019-07-19 4 STKL SunOpta Inc.
Common Shares
A - Award 5,243 55,670 10.40 3.29 17,249 183,154
2019-06-18 2019-06-14 4 STKL SunOpta Inc.
Restricted Stock Units
A - Award 24,194 24,194
2019-05-29 2019-05-24 4 STKL SunOpta Inc.
Restricted Stock Units
M - Exercise -11,688 0 -100.00
2019-05-29 2019-05-24 4 STKL SunOpta Inc.
Common Shares
M - Exercise 11,688 50,427 30.17
2019-04-29 2019-04-25 4 STKL SunOpta Inc.
Common Shares
A - Award 4,985 38,739 14.77 3.46 17,248 134,037
2019-01-18 2019-01-17 4 STKL SunOpta Inc.
Common Shares
A - Award 4,492 33,754 15.35 4.18 18,777 141,092
2018-10-19 2018-10-17 4 STKL SunOpta Inc.
Common Shares
A - Award 2,177 29,262 8.04 7.35 16,001 215,076
2018-07-16 2018-07-12 4 STKL SunOpta Inc.
Common Shares
A - Award 1,905 27,085 7.57 8.40 16,002 227,514
2018-07-16 2018-05-24 4 STKL SunOpta Inc.
Restricted Stock Units
A - Award 11,688 11,688
2018-05-29 2018-05-24 4 STKL SunOpta Inc.
Restricted Stock Units
M - Exercise -9,474 0 -100.00
2018-05-29 2018-05-24 4 STKL SunOpta Inc.
Common Shares
M - Exercise 9,474 25,180 60.32
2018-04-09 2018-04-06 4 STKL SunOpta Inc.
Common shares
A - Award 2,077 15,706 15.24 7.10 14,747 111,513
2018-01-17 2018-01-15 4 STKL SunOpta Inc.
Common shares
A - Award 2,227 13,629 19.53 7.75 17,259 105,625
2017-11-13 2017-11-08 4 STKL SunOpta Inc.
Restricted Stock Units
M - Exercise -7,995 0 -100.00
2017-11-13 2017-11-08 4 STKL SunOpta Inc.
Common Shares
M - Exercise 7,995 11,402 234.66
2017-10-18 2017-10-16 4 STKL SunOpta Inc.
Common Shares
A - Award 1,839 3,407 117.28 8.70 15,999 29,641
2017-07-20 2017-07-18 4 STKL SunOpta Inc.
Common shares
A - Award 1,568 1,568
2017-05-26 2017-05-24 4 STKL SunOpta Inc.
Restricted Stock Units
A - Award 9,474 9,474
2016-11-10 2016-11-08 4 STKL SunOpta Inc.
Restricted Stock Units
A - Award 7,995 13,317 150.23
2016-11-10 2016-11-08 4 STKL SunOpta Inc.
Stock Option (right to buy)
A - Award 5,322 5,322
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)